Tyercan

company

About

Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs.

Details

Last Funding Type
Angel
Industries
Biotechnology,Health Care,Medical,Pharmaceutical,Product Research
Founded date
Jan 1, 2017
Operating Status
Active

Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Tyercan has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 1, 2021 from a Angel round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2021 Angel 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Tyercan is funded by 1 investors. BIOCHING CAPITAL are the most recent investors.
Investor Name Lead Investor Funding Round
BIOCHING CAPITAL Angel